In view of the controversy related to the generation of off--target mutations by gene editing approaches, we tested the specificity of TALENs by disrupting a multi--copy gene family using only one pair of TALENS. We show here that TALENS do display a high level of specificity by simultaneously knocking out the function of the three genes that encode for H2A.B.3. This represents the first described knockout of this histone variant.
Despite being discovered over a decade ago 1 , the in vivo importance of the mammalian histone H2A variant H2A.B remains unknown. H2A.B appeared late in evolution in mice (H2A.B.3) and humans (H2A.B), and it is predominantly expressed in the testis with low expression levels in the brain 2, 3 . The availability of a H2A.B.3 knockout would be an invaluable tool for investigating the importance of H2A.B, however, as the H2A.B.3 protein is expressed from three different genes, this is a technically challenging feat. Our aim was to devise the most efficient and specific strategy to inhibit the function of all three genes.
Here, we report a simplified TALEN approach that achieves this goal.
Previously, transcription activator--like effector nucleases (TALENs) were the choice to perform gene and genome editing 4,5 but more recently this technology has been superseded by the CRISPR--Cas9 system 6 . However, while improvements are continually being made 7--9 , one issue has been the extent of off--targets mutants generated with the use of CRISPR--Cas9, which appears to be greater when compared with TALENs 10--13 . One attractive feature of TALENs, which enables a higher level of specificity, is that the FOK1 nuclease domain will only cleave DNA when dimerized, which occurs when the two TALE--domains bind to DNA (on opposite strands) in close proximity to each other. Here, we used
TALENs to genetically impair the function of all three H2A.B.3 encoding genes and moreover, we used only one pair of TALENS to do this. To our knowledge, this has not been done before.
There are three H2A.B.3--encoding genes (H2Afb3, Gm14920, H2Afb2, which are >92% identical) plus a pseudogene (Gm14904) all located on the X chromosome in the mouse (this pseudogene was present in the Ensemble release 57 but subsequently removed) Cel1 assays confirmed these findings (Supplementary Fig. 3 ). These in vitro results demonstrate the high specificity of TALENs; some of the targeted DNA sequences of the first group, designed against the H2Afb3 gene, differed by only 2--3 base pairs compared to the second group, and yet specificity for only the H2Afb3 gene was achieved ( Supplementary   Fig.  4 ). The TALEN pair 101421:101422 was used to knock out (KO) the function of all three H2A.B.3 genes in mice ( Supplementary Fig. 4 ).
Prior to creating the H2A.B.33 KO, we determined whether any off--target genomic locations, which have limited sequence homology to the TALEN pair 101421:101422, can be identified by using NCBI BLAST against the mouse reference genome mm10 built on the C57BL/6J strain. Even relaxing this BLAST search to only 8 bp out of the 15 bp DNA recognition sequence returned no matches (data not shown).
In order to produce H2A.B.3 KO mice, FVB/NJArc mice (derived in Jackson Laboratories and sourced from Australian Animal Resource Centre (ARC), hence an extra suffix, JArc)
were used. Capped, poly--adenylated and purified in vitro transcribed mRNA was adjusted to 10 ng/µl for each TALEN pair (101421:101422) and injected into 532 fertilised one--cell embryos and cultured overnight to the 2--cell stage. 153 surviving 2--cell embryos that displayed normal morphology were implanted in pseudo pregnant females, resulting in the birth of 19 pups. Of these 19 pups, 9 contained TALEN--induced H2A.B.3 mutations. Most interestingly, TALENs activity produced an all--or--nothing effect, i.e., for each of the 9 founder pups, all three H2A.B.3 genes were mutated while for the 10 unmodified pups, no gene copies of H2A.B.3 were modified (Table  1) . Moreover, in female pups, both alleles of H2Afb3, Gm14920 and H2Afb2 were modified, and each H2A.B.3 gene contained a unique indel as the result of TALEN activity (identified by Sanger sequencing). Therefore, one pair of TALENS can edit 6 homologous alleles simultaneously.
Most of the mutants carried small deletions. Interestingly, in 2 founders, L90--4 and L90--8, at least one of the H2A.B.3 genes (usually gm14920 or H2Afb2) was not amplifiable by PCR. However, when we used mixed primer pairs for PCR amplification (e.g. gm14920--forward and H2Afb2--reverse) we were able to detect an amplification product and following Sanger DNA sequencing, demonstrated that a fusion between gm14920 and H2Afb2 had occurred (data not shown). Also unexpectedly, when the founder L74--5 mouse, which only displayed the deletions and insertions described in Table  1 , was bred with a wild--type (wt) female, the resulting G1 progeny displayed a chimera between the gm14920 and H2Afb2 genes ( Supplementary Fig. 5 ). Continued breeding from these chimeric G1 H2A.B.3 --/x females with wt males (up to 4 generations), revealed that these additional mutations were lost after G2, but maintained original founder mutations (H2Afb3 X ∆+286 , gm14290 X ∆15 , H2Afb2 X ∆17 ). This can be explained by the fact that TALEN activity can be retained for several cell divisions following their injection into the 2--cell stage, thus producing a mosaic genotype, as previously observed 14, 15 . Collectively, the G1 generation of the 9 founder H2A.B.3 genetically modified mice produced 22/78 mice displaying mosaicism, but by G3 a pure non--mosaic mouse colony was derived.
The strategy for the identification of possible TALEN--induced off--target mutations in H2A.B.3 --/y mice was based on the sequencing of exomes of three related non--mosaic H2A.B.3 --/y mice from three consecutive generations (G1--G3). This strategy avoids the problem observed in previous studies where unrelated mice were compared to assess off--target effects 12 . Each exome sample was sequenced using 100bp paired--end reads on the Illumina HiSeq 2000 sequencer to a depth of 350 --600x coverage, yielding between 129x10 6 and 228x10 6 reads per sample (Supplementary Table 3 mice for exon sequencing. By crossing mutant females with wt. males any true off--target mutations would be identified because they would be diluted by 50% after each generation.
On the other hand, natural sequence variations due to mouse strain differences would not be diluted by breeding (see below). Sequenced mouse exomes were run through our in--house variant detection pipeline (see Online Methods) to detect SNVs, small indels and larger structural variants. Importantly, TALENS do not usually produce SNVs, thus this type of variant serves as an internal measure for mouse strain differences.
As expected, alignment with the mm10 genome identified a large number of SNVs (~1.7x10 6 for G1 and G2, and ~0.69x10x 6 for G3) and indels (~1.7x10 5 for G1 and G2, 0.6x10 5 for G3) (Supplementary Table 4), however neither followed a dilution pattern but rather correlated with the original number of sequencing reads. To remove the effect of mouse strain differences, a filter for FVB/NJ was included into the alignment, which indeed greatly reduced the number of SNVs and indels (Supplementary Table 5 ). Again, the remaining SNVs and putative indels did not follow a dilution pattern following successive
generations.
An additional analysis was conducted to separate heterozygous from homozygous indels 16 . As shown (Supplementary Table 6 ), after filtering against the FVB/NJ genome, 417
NM4--G1, 420 NM4--G2 and 325 NM4--G3 heterozygous (0/1+0/2+1/2) indels remained after alignment with the mm10 genome, but again did not display a 50% dilution pattern from G1--G3. To provide further evidence that these remaining indels are due to strain differences between FVB/NJArc and FVB/NJ mice, we interrogated the 19 indels common to all three NM4 G1--G3 mice ( Supplementary  Fig.  6 , the location of these putative indels are shown in Supplementary Table 7) .
We amplified 300--450 bp regions spanning all 19 indels and compared them to the wt FVB/NJArc mice. The results for all 19 regions (Fig. 1a) clearly show that the amplified fragments were identical in size for the H2A.B.3 --/y and wt FVB/NJArc mice. Furthermore, we sequenced 5 of these putative indels, which confirmed that the H2A.B.3 --/y and wt mice are identical in the nucleotide sequence where the indels were predicted to be ( Fig.  1b  and  c) .
Further, the computational prediction tools are often inaccurate, not only in predicting the size of a putative deletion but also in falsely predicting that a deletion exists ( Fig. 1c and d) .
Overall, our results suggest that the predicted indels in our H2A.B.3 --/y are due to DNA sequence differences in our in--house FVB/NJArc mouse strain, and computational errors in predicting indels. Finally, to detect structural variants in NM4--G1, NM4--G2 and NM4--G3, analyses using Pindel and Janda were performed. In addition to the three expected deletions in H2A.B.3 genes: H2Afb3 (5 bp), gm14920 (10 bp), a larger deletion of 64 bp in H2Afb2 was also detected (Supplementary Fig. 7 ).
Despite the fact that H2A.B.3--deficient mice produce neither wt H2A.B.3 mRNA nor protein ( Supplementary Fig. 8a and b) , they can obviously reproduce. To investigate whether the loss of H2A.B.3 does affect fertility, we set up a breeding regime whereby age--matched male wt H2A.B.3 and H2A.B.3 --/y were mated with 3--6 month female mice and the litter sizes were recorded ( Supplementary  Fig.  8c ). The results showed that H2A.B.3 --/y mice were subfertile, producing significantly smaller litter sizes and thus demonstrating that H2A.B.3 is required for fertility.
In conclusion, a major ongoing question is whether a RNA (e.g. CRISPR)--or protein (e.g. TALEN)--based mechanism will ultimately prove to be more specific for genome editing and this will be critical for future medical therapies. In this study, we have successfully applied the TALEN technology, whereby we used one pair of TALENs to specifically and simultaneously disrupt three gene copies of a gene family. Many human diseases are caused by gene copy number variations 17 and therefore the use of a limited number of genome editing enzymes might help in the future treatment of such diseases. The use of only one pair of TALENs, rather than multiple pairs, reduces the complexity of the TALEN approach (and hence the cost) and would reduce the likelihood of mosaicism and most importantly, reduce the possibility of off--target mutations. Indeed, our rigorous exome analyses did not reveal any TALEN--induced off--target mutations. We also found that the computational tools used to predict putative SNVs and indels have limitations, and therefore wet--lab validation is required before any conclusions can be made about off--target mutations.
Finally, the TALEN approach did expose several interesting phenomena. Firstly, the simultaneous knockout of highly homologous H2A.B.3 genes leads to the formation of chimeras between these genes. As every chimera contained a small deletion, it is likely that terminal microhomology, a mechanism of NHEJ, was involved 18 . It is important to point out that other technologies that rely on NHEJ for inducing mutations, like CRISPR/Cas9 technology, will also likely produce chimeras between highly homologous genes. Several rounds of backcrossing can successfully eliminate such small--scale genomic rearrangements.
Secondly, we observed an all--or--nothing effect whereby the TALENs either modified all 3 H2A.B.3 genes or modified none, which reduced the need for a more complex breeding and screening strategy to establish a H2A.B.3 KO colony.
METHODS
Methods are available in the online version of the paper.
Note: Any Supplementary Information is available on the online version of the paper.
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TALEN Design.
The TALENs were assembled using the method previously described 5, 19 . The TALEN target sites were searched using a computer script developed in Sangamo. The four most common repeat variable diresidue (RVD), NI, HD, NN and NG, were used to recognize bases A, C, G and T, respectively. The NK RVD was sometimes used to specify the 3' half repeat T base.
TALENs were generated by linking several pre--made TALE repeat blocks in the forms of monomer, dimer, trimer, or tetramer. The desired repeat blocks were PCR amplified using position--specific primers. The PCR products were pooled, digested with BsaI and ligated into the TALEN expression vector, pVAXt--3Flag--NLS--TALE--Bsa3--C63--FokI, which had been linearized with the BsaI restriction enzyme. Ligations were transformed into E. coli competent cells, and single clones were picked and sequence verified. 
Talen mRNA synthesis.
Plasmids (in Sangamo backbone) were linearized with XbaI and the products were purified (PCR Cleanup kit, Qiagen). Using linearized plasmid as template, capped and poly(A)--tailed mRNA transcripts were produced using mMESSAGE mMACHINE T7 Ultra Transcription Kit (Life Technologies) following manufacturer's instructions. mRNA was purified using a MEGAclear kit (Life Technologies) and was eluted in RNase--free water and single--use aliquots were frozen.
Production of Talen--mediated genetically modified mice.
All mouse work was conducted according to protocols approved and authorised by the University of Queensland Animal and the Australian National University Ethics Committee (Protocol A2014/33). Prior to injection, mRNA was diluted to 10 ng/µl in filtered RNase--free microinjection buffer (10 mM Tris--HCl, pH 7.4, 0.25 mM EDTA). TALEN mRNA was delivered into the pronucleus of single--cell embryos (FVB), using standard techniques. Injected embryos were cultured overnight to the two--cell stage, then surgically transferred into oviducts pseudopregnant CD1 mice, using standard techniques.
Analysis of potential founders and genotyping of successive generations.
Transgenic founders with mutated H2A.B.3 genes were identified among live born mice by PCR (Supplementary Table  8 ) genotyping of ear notch tissue. Genomic DNA was extracted from ear punches using Quick Extract Solution (Epicentre) following manufacturer's instructions. The H2afb3, gm14920 and H2afb2 genes were amplified in 25µl volume using the same gene--specific primers as for the Cel1 assay. PCR mix (1x Platinum Taq buffer, 1.5mM Mg2Cl; 0.2mM dNTP; 0.2µM of forward and reverse primer; 2 units of Platinum Taq polymerase (Thermo Fisher)) was amplified using 28 cycles of: 95°C 30s denaturation, followed by 56--65°C, 30s annealing and 72°C, 4min extension.
Exome Sequencing and bioinformatic analyses.
The male mice that were chosen for exome sequencing were genotyped prior to sequencing to confirm that all three generations had the same H2A.B.3 genotype (H2Afb3 (X ∆5 Y), gm14920 (X ∆10 Y) and H2Afb2 (X ∆64 Y)). The purified gDNA was subjected to exome enrichment using the Agilent SureSelect XT2 All Exon Kit. The exome capture efficiency was uniformly high with approximately 45--50 % of all DNA sequenced being exonic. Sequenced mouse exomes were analyzed using our in--house variant detection pipeline described in detail previously 20, 21 . In short, reads were aligned to the mouse reference genome mm10 using BWA 22 and sorted BAM alignment files were generated using 27 . We used the TALEN target sequences as forward and reverse primers, and relaxed the minimum perfect match parameter to 8 nucleotides (nt) and constrained the maximum product size to 100bp.
Experimentally validation of putative indels.
To interrogate whether the 19 putative indels are present in NM4 G1--G3 mice, the gDNA of wild type FVB/NJArc in--house mice and NM4 G1--G3 KO mice were amplified with primers surrounding the predicted indels, listed in Supplementary 
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